Ryan Specialty Group (RYAN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
12 Feb, 2026Executive summary
Q2 2025 total revenue rose 23% year-over-year to $855.2 million, driven by 7.1% organic growth and significant M&A activity, with net income up 5.6% to $124.7 million.
Adjusted EBITDAC increased 24.5% to $308.4 million, margin expanded to 36.1%, and adjusted EPS rose 13.8% to $0.66.
Major acquisitions (USQRisk, 360° Underwriting, JM Wilson, Velocity Risk Underwriters) expanded specialty capabilities and geographic reach.
Strategic alliances, including with Nationwide Mutual and Markel, are expanding business opportunities and delegated authority.
Focus remains on strategic acquisitions, broker relationships, and investments in technology and operational growth.
Financial highlights
Q2 revenue reached $855.2 million, up 23% year-over-year, with net commissions and fees up 23.6% to $840.9 million.
Adjusted EBITDAC margin improved to 36.1%, and adjusted net income margin was 21.6%.
Adjusted EPS was $0.66, and diluted EPS was $0.38 for Q2 2025.
Net income margin decreased to 14.6% from 17.0% year-over-year due to higher amortization and interest expense.
Compensation and benefits expense ratio improved to 56.7% from 59.5% year-over-year.
Outlook and guidance
Full-year 2025 organic revenue growth guidance revised to 9%-11%, reflecting property pricing declines and strong acquisition activity.
Adjusted EBITDAC margin guidance set at 32.5%-33%, with a target of 35% by 2027.
Q3 organic revenue growth expected to exceed Q2 and Q4, with property remaining a headwind.
Investments in talent and alternative risk will impact margins in H2 2025 but are expected to be accretive from 2026.
Management anticipates sufficient liquidity and capital resources to fund growth initiatives over the next 12 months.
Latest events from Ryan Specialty Group
- Record revenue, expanded shareholder rights, and a focus on performance-based leadership mark 2025.RYAN
Proxy Filing17 Mar 2026 - Shareholders will vote on director elections, auditor ratification, and executive pay approval.RYAN
Proxy Filing17 Mar 2026 - 2025 revenue up 21.3% to $3.1B, with 10.1% organic growth and $300M buyback authorized.RYAN
Q4 202527 Feb 2026 - Q3 revenue up 25% and net income up 118.6%, with strong organic growth and margin pressures from investments.RYAN
Q3 202512 Feb 2026 - Double-digit growth and E&S market leadership driven by complexity, scale, and innovation.RYAN
Investor presentation12 Feb 2026 - Revenue up 18.8%, net income up 40.8%, with margin and guidance both raised.RYAN
Q2 20242 Feb 2026 - Double-digit growth and margin expansion are fueled by E&S specialization, M&A, and innovation.RYAN
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Strategic acquisitions, leadership continuity, and E&S market growth drive future expansion.RYAN
2024 KBW Insurance Conference22 Jan 2026 - Q3 revenue up 20.5%, net income up 82.4%, and adjusted EBITDA up 29.4% year-over-year.RYAN
Q3 202417 Jan 2026